Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1995-05-22
1998-10-20
Cain, Edward J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
530303, A61K 3726
Patent
active
058246380
ABSTRACT:
A pharmaceutical preparation for oral insulin delivery comprising a stable, hydrophobic emulsion comprising continuous phase of a hydrophobic material selected from the group consisting of a long chain carboxylic acid or ester or alcohol thereof dispersed in an aqueous phase or (ii) having a hydrophilic discontinuous phase dispersed in a hydrophobic phase of a long chain carboxylic acid or alcohol thereof. The emulsion with insulin is incorporated into a pharmaceutical carrier suitable for oral delivery.
REFERENCES:
patent: 4083973 (1978-04-01), van der Vies
patent: 4115313 (1978-09-01), Lyon et al.
patent: 4224179 (1980-09-01), Schneider
patent: 4330338 (1982-05-01), Banker
patent: 4606913 (1986-08-01), Aronson et al.
patent: 4690775 (1987-09-01), Schott et al.
patent: 4784845 (1988-11-01), Desai et al.
patent: 4869897 (1989-09-01), Chatterjee et al.
patent: 4990337 (1991-02-01), Kurihara et al.
patent: 5143934 (1992-09-01), Lading et al.
patent: 5206219 (1993-04-01), Desai
patent: 5342625 (1994-08-01), Hauer et al.
Constantinides et al., Formulation & Intestinal Absorption Enhancement Evaluation of Water-in-Oil Microemulsions Incorporating Medium-Chain Glycerides, Pharm.Research., vol. 11, No. 10, pp. 1385-1390, (1994).
Ritschel et al., Improvement of Peroral Absorption of Cyclosporine A by Microemulsions, Meth. Find.Exp. Clin, Pharmacol, 12(2):127-134, (1990).
Shichiri et al., Increased Intestinal Absorption of Insulin in a Micellar Solution, First Dept. of Medicine, Osaka Univ. Medical School, pp. 175-183, (1977).
Ritschel, Microemulsions for Improved Peptide Absorption from the Gastrointestinal Tract, Meth. Find. Exp. Clin. Pharmacol., 13(3): 205-220, (1991).
Kararli et al., Oral Delivery of a Renin Inhibitor Compound Using Emulsion Formulations, Pharm.Research, vol,9, No.7, pp. 888-893, (1992).
Myers et al., Systemic Bioavailability of Penclomedine (NSC-338720) from Oil-in-water emulsions Administered Intraduodenally to Rats, Int'l, Jnl. of Pharmaceutics, 78:217-226, (1992).
Bhargava et al., Using Microemulsions for Drug Delivery, Pharm. Tech., pp. 47-51, (Mar. 1987).
Sarciaux et al., Using Microemulsion Formulations for Oral Drug Delivery of Therapeutic Peptides, Intl'l. Jnl. of Pharmaceutics, 120:127-136, (1995).
Constantinides et al., Pharmaceutical Research, 11:1385-1390, 1994.
Belendiuk, deceased George W.
Burnside Beth A.
Mattes Carol E.
McGuinness Charlotte M.
Rudnic Edward M.
Cain Edward J.
Olstein Elliot M.
Semionow Raina
Shire Laboratories Inc.
LandOfFree
Oral insulin delivery does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Oral insulin delivery, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Oral insulin delivery will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-244245